Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Allergy
|
December 3, 2009
Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions
A Vultaggio, A Matucci, F Nencini, et al.
Allergy
|
May 3, 2018
IgG4 anti-infliximab in treated patients: Clinical impact and temporal evolution
A Vultaggio, F Nencini, A Carraresi, et al.
Journal of Investigational Allergology & Clinical Immunology
|
December 22, 2021
Benralizumab: Resolution of Eosinophilic Pulmonary Vasculitis in a Patient With EGPA
S Bormioli, A Vultaggio, F Nencini, et al.
Clinical and Experimental Immunology
|
August 30, 2016
Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions
A Vultaggio, G Petroni, S Pratesi, et al.
International Journal of Immunopathology and Pharmacology
|
October 13, 2012
Vav1 haploinsufficiency in a common variable immunodeficiency patient with defective T-cell function
N Capitani, F Ariani, A Amedei, et al.
European Journal of Neurology
|
September 21, 2007
Influence of impaired T- and B-cell compartments on efficacy of IVIg in dysimmune neuropathies
S Matà, S Corzani, R Biagiotti, et al.
Journal of Investigational Allergology & Clinical Immunology
|
December 5, 2017
Different Skin Prick Test Sensitization Patterns Do Not Influence the Response to Omalizumab in Severe Asthma
B Sposato, M Scalese, M Milanese, et al.
Frontiers in Immunology
|
August 21, 2023
Case Report: A child with NFKB1 haploinsufficiency explaining the linkage between immunodeficiency and short stature
S Ricci, S Abu-Rumeileh, N Campagna, et al.
European Annals of Allergy and Clinical Immunology
|
June 26, 2026
Clinical experience with berotralstat in patients with hereditary angioedema: an Italian case series from the ITACA cohort
A Zanichelli, F Arcoleo, V Montinaro, et al.
European Journal of Internal Medicine
|
February 4, 2018
Factors reducing omalizumab response in severe asthma
B Sposato, M Scalese, M Milanese, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Allergy
|
December 3, 2009
Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions
A Vultaggio, A Matucci, F Nencini, et al.
Allergy
|
May 3, 2018
IgG4 anti-infliximab in treated patients: Clinical impact and temporal evolution
A Vultaggio, F Nencini, A Carraresi, et al.
Journal of Investigational Allergology & Clinical Immunology
|
December 22, 2021
Benralizumab: Resolution of Eosinophilic Pulmonary Vasculitis in a Patient With EGPA
S Bormioli, A Vultaggio, F Nencini, et al.
Clinical and Experimental Immunology
|
August 30, 2016
Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions
A Vultaggio, G Petroni, S Pratesi, et al.
International Journal of Immunopathology and Pharmacology
|
October 13, 2012
Vav1 haploinsufficiency in a common variable immunodeficiency patient with defective T-cell function
N Capitani, F Ariani, A Amedei, et al.
European Journal of Neurology
|
September 21, 2007
Influence of impaired T- and B-cell compartments on efficacy of IVIg in dysimmune neuropathies
S Matà, S Corzani, R Biagiotti, et al.
Journal of Investigational Allergology & Clinical Immunology
|
December 5, 2017
Different Skin Prick Test Sensitization Patterns Do Not Influence the Response to Omalizumab in Severe Asthma
B Sposato, M Scalese, M Milanese, et al.
Frontiers in Immunology
|
August 21, 2023
Case Report: A child with NFKB1 haploinsufficiency explaining the linkage between immunodeficiency and short stature
S Ricci, S Abu-Rumeileh, N Campagna, et al.
European Annals of Allergy and Clinical Immunology
|
June 26, 2026
Clinical experience with berotralstat in patients with hereditary angioedema: an Italian case series from the ITACA cohort
A Zanichelli, F Arcoleo, V Montinaro, et al.
European Journal of Internal Medicine
|
February 4, 2018
Factors reducing omalizumab response in severe asthma
B Sposato, M Scalese, M Milanese, et al.
Page
of 3